Ranibizumab for serous macular detachment in branch retinal vein occlusions.
about
Correlation between short- and long-term effects of intravitreal ranibizumab therapy on macular edema after branch retinal vein occlusion: a prospective observational study.Bevacizumab treatment for acute branch retinal vein occlusion accompanied by subretinal hemorrhage.Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion.Predicting the visual acuity for retinal vein occlusion after ranibizumab therapy with an original ranking for macular microstructure.Effect of intravitreal ranibizumab on serous retinal detachment in branch retinal vein occlusion
P2860
Ranibizumab for serous macular detachment in branch retinal vein occlusions.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Ranibizumab for serous macular detachment in branch retinal vein occlusions.
@en
Ranibizumab for serous macular detachment in branch retinal vein occlusions.
@nl
type
label
Ranibizumab for serous macular detachment in branch retinal vein occlusions.
@en
Ranibizumab for serous macular detachment in branch retinal vein occlusions.
@nl
prefLabel
Ranibizumab for serous macular detachment in branch retinal vein occlusions.
@en
Ranibizumab for serous macular detachment in branch retinal vein occlusions.
@nl
P2093
P2860
P1476
Ranibizumab for serous macular detachment in branch retinal vein occlusions.
@en
P2093
Antonio Lleó-Pérez
Diamar Pardo-López
J Fernando Arévalo
Manuel Díaz-Llopis
Roberto Gallego-Pinazo
Sebastián Martínez-Castillo
P2860
P2888
P356
10.1007/S00417-012-2023-7
P577
2012-04-25T00:00:00Z